◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

GenFleet Therapeutics (Shanghai) Inc. (2595) Financial History

Name: GenFleet Therapeutics (Shanghai) Inc. (2595) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-08-10

GenFleet Therapeutics (Shanghai) Inc. (2595) operates in the Biotechnology industry and is headquartered in Shanghai, China. Its market capitalization is roughly CNY 11 billion. In the fiscal year ended 2025-12-31, 2595 reported CNY 130M in revenue and (CNY 1.8B) in net income.

GenFleet Therapeutics (Shanghai) Inc., a biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.

Interactive charts & full statements →

2595 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31
Total Revenue	CNY 130M	CNY 105M	CNY 74M
Gross Profit	CNY 84M	CNY 85M	CNY 73M
Operating Income (EBIT)	(CNY 277M)	(CNY 299M)	(CNY 268M)
Net Income	(CNY 1.8B)	(CNY 678M)	(CNY 508M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2595 Free Cash Flow History

2595 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31
Total Assets	CNY 2.2B	CNY 607M	CNY 536M
Total Liabilities	CNY 381M	CNY 2.6B	CNY 1.9B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2595 viewer.

Other Companies in Biotechnology

9688 · Zai Lab Limited — $19 billion
9606 · Duality Biotherapeutics, Inc. — $18 billion
7666 · METIS TECHBIO-P — $13 billion
2142 · HBM Holdings Limited — $13 billion
1672 · Ascletis Pharma Inc. — $11 billion
4875 · MediciNova, Inc. — $10 billion
2493 · MABWELL-B — $10 billion
6872 · TENNOR THERAP-B — $10 billion

← 2594 All “0-9” companies 2596 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.